Notify me when Finian Tan files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| AARD | Aardvark Therapeutics, Inc. | Common Stock | 9.6% | $23,441,810 | 2,050,902 | Vickers Venture Fund VI Pte. Ltd. | 12 Feb 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|